BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11724349)

  • 1. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB; Bandea C; Swan D; Abbott K; Varma VA
    Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas.
    Patt S; Gries H; Giraldo M; Cervos-Navarro J; Martin H; Jänisch W; Brockmöller J
    Hum Pathol; 1996 Jun; 27(6):586-9. PubMed ID: 8666369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
    Zhang X; Fu Y; Liu S; Liang C
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
    Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S
    Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutations by PCR-SSCP analysis and immunohistochemistry.
    Koga H; Zhang S; Ichikawa T; Washiyama K; Kuroiwa T; Tanaka R; Kumanishi T
    Noshuyo Byori; 1994; 11(2):151-5. PubMed ID: 7894617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the p53 gene in gliomas from Malay patients.
    Jafri A; Aziz MY; Ros S; Nizam I
    Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.